speb/financial-data huggingface dataset:
HCG.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 193540000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 357760000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 357760000.00
HCG.NS income_statement (annual, 2025-03-31) — Pretax Income: 569600000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 136200000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
HCG.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 106700000.00
HCG.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -1971900000.00
HCG.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -1179000000.00
HCG.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -2088700000.00
HCG.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 10622700000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2832300000.00
HCG.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 2113400000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 580700000.00
HCG.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 269370000.00
HCG.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 269370000.00
HCG.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -775600000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 1118260000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1118260000.00
HCG.NS income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: -27820000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -4092380000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -4092380000.00
HCG.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 252200000.00
HCG.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 15400000.00
HCG.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 462650000.00
HCG.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 1063870000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Share Issued: 140277065.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 140277065.00
HCG.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
HCG.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
HCG.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 65400000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 9224440000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 9224440000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 4269780000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4269780000.00
HCG.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
HCG.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
HCG.NS income_statement (annual, 2025-03-31) — Tax Provision: 81300000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 68500000.00
HCG.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.14
HCG.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
HCG.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 56300000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 56300000.00
HCG.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -318800000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Total Assets: 35432360000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 35432360000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 15270280000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 15270280000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Total Debt: 18372210000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 18372210000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 9900490000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 9900490000.00
HCG.NS income_statement (annual, 2025-03-31) — Total Expenses: 20422000000.00
HCG.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 5357800000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 25531870000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 25531870000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 26994390000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 26994390000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 15067690000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 15067690000.00
HCG.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 77290000.00
HCG.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 26370000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 26370000.00
HCG.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
HCG.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
HCG.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
HCG.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
HCG.NS balance_sheet (annual, 2025-03-31) — Working Capital: -2026210000.00
HCG.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: -2026210000.00
HCG.NS income_statement (annual, 2025-03-31) — Write Off: 97270000.00
HCG.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 2670300000.00
HCG.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 6118000000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 140569374.00
HCG.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.34
HCG.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2948900000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 579100000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 579100000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 140569374.00
HCG.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.34
HCG.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 47500000.00
HCG.NS income_statement (quarterly, 2025-06-30) — EBIT: 573900000.00
HCG.NS income_statement (quarterly, 2025-06-30) — EBITDA: 1153000000.00
HCG.NS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 15700000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 3169100000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 454700000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 454700000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -12300000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Net Income: 47500000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 47500000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 59800000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 47500000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 47500000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 59800000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -454700000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -454700000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1153000000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 47500000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Operating Income: 498800000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 6118000000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 68300000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1111400000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
HCG.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 119200000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2948900000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 579100000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 15700000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
HCG.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
HCG.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 59400000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
HCG.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 5619200000.00
HCG.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
HCG.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
HCG.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 2709000000.00
HCG.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 6451600000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3829700000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 4318800000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 732400000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 141125529.00
HCG.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.15
HCG.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 8639300000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1410000000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1826100000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2117800000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 1410000000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 9206200000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 958600000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 3137500000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 7637700000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 598600000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 2888100000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 3486700000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 10398000000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 182800000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 628000000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 628000000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 141125529.00
HCG.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.15
HCG.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 162700000.00
HCG.NS income_statement (quarterly, 2025-09-30) — EBIT: 634400000.00
HCG.NS income_statement (quarterly, 2025-09-30) — EBITDA: 1262400000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 4299800000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 4709100000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 20514600000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 3314100000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 436200000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 436200000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 615500000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 18245700000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 732400000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 8040700000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 6151400000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 14192100000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 54800000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 222700000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 731000000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -43900000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 7213400000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Net Income: 162700000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 162700000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 206600000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 162700000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 162700000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 206600000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -436200000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -436200000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 20514600000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4497100000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 366000000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 30500000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1262400000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 162700000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Operating Income: 605100000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 6451600000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 141871590.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 548200000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 746700000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 7796200000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 409300000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 726800000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 415500000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 26200000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1156100000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 19556000000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 37400000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 291700000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Payables: 4020000000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 198200000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 3137500000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 628000000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 141871590.00
HCG.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 9206200000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4497100000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
HCG.NS income_statement (quarterly, 2025-09-30) — Tax Provision: -8400000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
HCG.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 35856000000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 15357600000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 17678800000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 9937200000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 5846500000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 25918800000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 28218300000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 15520800000.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 190300000.00
HCG.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
HCG.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
HCG.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: -2760300000.00
HCG.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 2665300000.00
HCG.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 6311800000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 139533600.00
HCG.NS income_statement (quarterly, 2025-12-31) — Basic EPS: -0.68
HCG.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3156900000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 606500000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 606500000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 139533600.00
HCG.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.68
HCG.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -94300000.00
HCG.NS income_statement (quarterly, 2025-12-31) — EBIT: 387100000.00
HCG.NS income_statement (quarterly, 2025-12-31) — EBITDA: 993600000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 3154900000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 447800000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 447800000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -15300000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Net Income: -94300000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -94300000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -79000000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -94300000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -94300000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -79000000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -447800000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -447800000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1120300000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -5610000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Operating Income: 489600000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 6311800000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 24700000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1135900000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
HCG.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -60700000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 3156900000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 606500000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -126700000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -38010000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 18300000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
HCG.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 5822200000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -126700000.00
HCG.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -126700000.00
HCG.NS income_statement (annual, 2026-03-31) — +Operating Expense: 10754400000.00
HCG.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 2709800000.00
HCG.NS income_statement (annual, 2026-03-31) — +Total Revenue: 25384300000.00
HCG.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 6502900000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 3510400000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3510400000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 4207000000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4207000000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 667100000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 667100000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 894600000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 894600000.00
HCG.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 141855670.00
HCG.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 144666667.00
HCG.NS income_statement (annual, 2026-03-31) — Basic EPS: 0.97
HCG.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.15
HCG.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: -470700000.00
HCG.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -2921000000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 8249500000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 8249500000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 1493000000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1493000000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 5360500000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 5360500000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5522100000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5522100000.00
HCG.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -93800000.00
HCG.NS cash_flow (annual, 2026-03-31) — Change In Payable: 21100000.00
HCG.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -437900000.00
HCG.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -425400000.00
HCG.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 4103000000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Common Stock: 1493000000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1493000000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 13319700000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 13319700000.00
HCG.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 4488500000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 185600000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 185600000.00
HCG.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 12413700000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3170400000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Current Assets: 11352100000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 11352100000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 649700000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 649700000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Current Debt: 3112200000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 3112200000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 3761900000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 3761900000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 10171600000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 10171600000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 233800000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 233800000.00
HCG.NS cash_flow (annual, 2026-03-31) — Depreciation: 2441700000.00
HCG.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 2441700000.00
HCG.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 2441700000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 628100000.00
HCG.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 2441700000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 628100000.00
HCG.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 143333333.00
HCG.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 144666667.00
HCG.NS income_statement (annual, 2026-03-31) — Diluted EPS: 0.96
HCG.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.15
HCG.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 137600000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 21700000.00
HCG.NS income_statement (annual, 2026-03-31) — EBIT: 2034900000.00
HCG.NS income_statement (quarterly, 2026-03-31) — EBIT: 439500000.00
HCG.NS income_statement (annual, 2026-03-31) — EBITDA: 4476600000.00
HCG.NS income_statement (quarterly, 2026-03-31) — EBITDA: 1067600000.00
HCG.NS cash_flow (annual, 2026-03-31) — End Cash Position: 3632300000.00
HCG.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 2406700000.00
HCG.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 550000000.00
HCG.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -600000.00
HCG.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -2500000.00
HCG.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 25900000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Goodwill: 3875900000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 3875900000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 4204600000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 4204600000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 20597100000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 20597100000.00
HCG.NS income_statement (annual, 2026-03-31) — Gross Profit: 12970600000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 3332500000.00
HCG.NS income_statement (annual, 2026-03-31) — Interest Expense: 1765700000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 427000000.00
HCG.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1765700000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 427000000.00
HCG.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -1669800000.00
HCG.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 119200000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Inventory: 598200000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 598200000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 22423800000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 22423800000.00
HCG.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1774700000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 894600000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 894600000.00
HCG.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 4488500000.00
HCG.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 1286800000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 7599800000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 7599800000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 5991900000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 5991900000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 13591700000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 13591700000.00
HCG.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 1286800000.00
HCG.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -1190200000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 68200000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 68200000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 252600000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 252600000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 782400000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 782400000.00
HCG.NS income_statement (annual, 2026-03-31) — Minority Interests: -90200000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -18700000.00
HCG.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 0.00
HCG.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 4488500000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Net Debt: 3743600000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 3743600000.00
HCG.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -1500000.00
HCG.NS income_statement (annual, 2026-03-31) — Net Income: 137600000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Net Income: 21700000.00
HCG.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 137600000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 21700000.00
HCG.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 227800000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 40400000.00
HCG.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 137600000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 21700000.00
HCG.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 137600000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 21700000.00
HCG.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 269200000.00
HCG.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 227800000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 40400000.00
HCG.NS income_statement (annual, 2026-03-31) — Net Interest Income: -1765700000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -427000000.00
HCG.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 991000000.00
HCG.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 96600000.00
HCG.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 96600000.00
HCG.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1765700000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -427000000.00
HCG.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: 5900000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Net PPE: 20597100000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 20597100000.00
HCG.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -2884900000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 9115100000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 9115100000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 399200000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 399200000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 23400000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 23400000.00
HCG.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 4852400000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1386700000.00
HCG.NS income_statement (annual, 2026-03-31) — Normalized Income: 455606092.12
HCG.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 213160000.00
HCG.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 3471000000.00
HCG.NS income_statement (annual, 2026-03-31) — Operating Income: 2216200000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Operating Income: 622700000.00
HCG.NS income_statement (annual, 2026-03-31) — Operating Revenue: 25384300000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 6502900000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 149302203.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 149302203.00
HCG.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 324100000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 324100000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 388400000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 388400000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 11826700000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 11826700000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 328700000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 328700000.00
HCG.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 1551700000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 635400000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 635400000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 384500000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 384500000.00
HCG.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 179900000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 130700000.00
HCG.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 4570600000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1177400000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Other Properties: 20411500000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 20411500000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 33600000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 33600000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 161600000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 161600000.00
HCG.NS income_statement (annual, 2026-03-31) — Other Special Charges: 764900000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: 319100000.00
HCG.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
HCG.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
HCG.NS balance_sheet (annual, 2026-03-31) — Payables: 3546400000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Payables: 3546400000.00
HCG.NS income_statement (annual, 2026-03-31) — Pretax Income: 269200000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 12500000.00
HCG.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 218500000.00
HCG.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
HCG.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -1106200000.00
HCG.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -2921000000.00
HCG.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 12413700000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3170400000.00
HCG.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 2441700000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 628100000.00
HCG.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -1190200000.00
HCG.NS income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: -70000000.00
HCG.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 2097200000.00
HCG.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 36100000.00
HCG.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 25900000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Share Issued: 149302203.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 149302203.00
HCG.NS income_statement (annual, 2026-03-31) — Special Income Charges: -375800000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -319100000.00
HCG.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: -566400000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 13319700000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 13319700000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 9115100000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 9115100000.00
HCG.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -57793907.88
HCG.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -127640000.00
HCG.NS income_statement (annual, 2026-03-31) — Tax Provision: 41400000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -27900000.00
HCG.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.15
HCG.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
HCG.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -318200000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Total Assets: 39225400000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 39225400000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 19311600000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 19311600000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Total Debt: 17353600000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 17353600000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 14102100000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 14102100000.00
HCG.NS income_statement (annual, 2026-03-31) — Total Expenses: 23168100000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 5880200000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 25123300000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 25123300000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 27873300000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 27873300000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 14951700000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 14951700000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 36000000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 36000000.00
HCG.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -375800000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -319100000.00
HCG.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -375800000.00
HCG.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -319100000.00
HCG.NS balance_sheet (annual, 2026-03-31) — Working Capital: 1180500000.00
HCG.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1180500000.00
HCG.NS income_statement (annual, 2026-03-31) — Write Off: -319100000.00
HCH.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 59400.00
HCH.AX cash_flow (annual, 2021-06-30) — Common Stock Issuance: 28018525.00
HCH.AX cash_flow (annual, 2021-06-30) — Common Stock Payments: -1615800.00
HCH.AX balance_sheet (annual, 2021-06-30) — Current Debt: 4999787.00
HCH.AX balance_sheet (annual, 2021-06-30) — Current Provisions: 2729777.00
HCH.AX cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 28018525.00
HCH.AX cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 26402725.00
HCH.AX balance_sheet (annual, 2021-06-30) — Net Debt: 1395162.00
HCH.AX cash_flow (annual, 2021-06-30) — Other Cash Receiptsfrom Operating Activities: 59400.00
HCH.AX balance_sheet (annual, 2021-06-30) — Other Current Borrowings: 4999787.00
HCH.AX balance_sheet (annual, 2021-06-30) — Other Payable: 1995212.00
HCH.AX cash_flow (annual, 2021-06-30) — Repurchase Of Capital Stock: -1615800.00
HCH.AX cash_flow (annual, 2021-06-30) — Taxes Refund Paid Direct: -18185.00
HCH.AX income_statement (annual, 2022-06-30) — +Operating Expense: 6921061.00
HCH.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 6376830.00
HCH.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -815177.00
HCH.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 95854266.00
HCH.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.07
HCH.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 3604625.00
HCH.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -48882367.00
HCH.AX cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -25584862.00
HCH.AX balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 330848.00
HCH.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 269189573.00
HCH.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 23721808.00
HCH.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 23721808.00
HCH.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 23721808.00
HCH.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 75475078.00
HCH.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -48882367.00
HCH.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -6009057.00
HCH.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 20583654.00
HCH.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -6101583.00
HCH.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 91420.00
HCH.AX balance_sheet (annual, 2022-06-30) — Common Stock: 269189573.00
HCH.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 205922710.00
HCH.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 80636160.00
HCH.AX cash_flow (annual, 2022-06-30) — Common Stock Payments: -5060759.00
HCH.AX balance_sheet (annual, 2022-06-30) — Current Assets: 23791706.00
HCH.AX balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 67081.00
HCH.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 67081.00
HCH.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 6551279.00
HCH.AX balance_sheet (annual, 2022-06-30) — Current Provisions: 107368.00
HCH.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 90034.00
HCH.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 90034.00
HCH.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 90034.00
HCH.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 95854266.00
HCH.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.07
HCH.AX income_statement (annual, 2022-06-30) — EBIT: -4866831.00
HCH.AX income_statement (annual, 2022-06-30) — EBITDA: -4776797.00
HCH.AX cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: -466471.00
HCH.AX cash_flow (annual, 2022-06-30) — End Cash Position: 23721808.00
HCH.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 75475078.00
HCH.AX balance_sheet (annual, 2022-06-30) — Foreign Currency Translation Adjustments: 1222.00
HCH.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -54891424.00
HCH.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 5519071.00
HCH.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 3945501.00
HCH.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 208619142.00
HCH.AX income_statement (annual, 2022-06-30) — Interest Expense: 2411925.00
HCH.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 2411925.00
HCH.AX income_statement (annual, 2022-06-30) — Interest Income: 3688.00
HCH.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 3688.00
HCH.AX cash_flow (annual, 2022-06-30) — Interest Paid Direct: -2582.00
HCH.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 2582.00
HCH.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 3688.00
HCH.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 205922710.00
HCH.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -48882367.00
HCH.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 80636160.00
HCH.AX balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 263767.00
HCH.AX balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 263767.00
HCH.AX balance_sheet (annual, 2022-06-30) — Long Term Provisions: 9145.00
HCH.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 810615.00
HCH.AX balance_sheet (annual, 2022-06-30) — Minority Interest: 18848770.00
HCH.AX income_statement (annual, 2022-06-30) — Minority Interests: 132103.00
HCH.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 75575401.00
HCH.AX income_statement (annual, 2022-06-30) — Net Income: -7146653.00
HCH.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -7146653.00
HCH.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -7278756.00
HCH.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -7146653.00
HCH.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -7146653.00
HCH.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -7278756.00
HCH.AX income_statement (annual, 2022-06-30) — Net Interest Income: -2408237.00
HCH.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -2408237.00
HCH.AX cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -200646.00
HCH.AX balance_sheet (annual, 2022-06-30) — Net PPE: 207803965.00
HCH.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -23297505.00
HCH.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 205922710.00
HCH.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -4776797.00